To include your compound in the COVID-19 Resource Center, submit it here.

Diazooxohexanoate-based prodrug of a GLS inhibitor for lymphoma

DISEASE CATEGORY: Cancer

INDICATION: Lymphoma

Cell culture studies identified a diazooxohexanoate-based prodrug of a GLS inhibitor that could help treat

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE